<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001363'>Craniosynostosis</z:hpo>, the premature fusion of the cranial sutures, is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> disorder with a prevalence of ∼1 in 2,200 (refs </plain></SENT>
<SENT sid="1" pm="."><plain>1,2) </plain></SENT>
<SENT sid="2" pm="."><plain>A specific genetic etiology can be identified in ∼21% of cases, including mutations of TWIST1, which encodes a class II basic helix-loop-helix (bHLH) transcription factor, and causes <z:e sem="disease" ids="C0175699" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Saethre-Chotzen syndrome</z:e>, typically associated with coronal <z:mp ids='MP_0000566'>synostosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Using exome sequencing, we identified 38 heterozygous TCF12 mutations in 347 samples from unrelated individuals with <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The mutations predominantly occurred in individuals with coronal <z:mp ids='MP_0000566'>synostosis</z:mp> and accounted for 32% and 10% of subjects with bilateral and unilateral pathology, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>TCF12 encodes one of three class I E proteins that heterodimerize with class II bHLH proteins such as TWIST1 </plain></SENT>
<SENT sid="6" pm="."><plain>We show that TCF12 and TWIST1 act synergistically in a transactivation assay and that mice doubly heterozygous for loss-of-function mutations in Tcf12 and Twist1 have severe coronal <z:mp ids='MP_0000566'>synostosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Hence, the dosage of TCF12-TWIST1 heterodimers is critical for <z:mpath ids='MPATH_458'>normal</z:mpath> coronal suture development </plain></SENT>
</text></document>